NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications

A Russo, Giacomo Oliveira, S Berglund, R Greco, V Gambacorta, N Cieri, C Toffalori, L Zito, F Lorentino, S Piemontese, M Morelli, Fabio Giglio, A Assanelli, MT Lupo Stanghellini, C Bonini, J Peccatori, F Ciceri, L Luznik, L Vago

Research output: Contribution to journalArticle

Abstract

The use of posttransplant cyclophosphamide (PT-Cy) as graft-versus-host disease (GVHD) prophylaxis has revolutionized haploidentical hematopoietic stem cell transplantation (HSCT), allowing safe infusion of unmanipulated T cell-replete grafts. PT-Cy selectively eliminates proliferating alloreactive T cells, but whether and how it affects natural killer (NK) cells and their alloreactivity is largely unknown. Here we characterized NK cell dynamics in 17 patients who received unmanipulated haploidentical grafts, containing high numbers of mature NK cells, according to PT-Cy-based protocols in 2 independent centers. In both series, we documented robust proliferation of donor-derived NK cells immediately after HSCT. After infusion of Cy, a marked reduction of proliferating NK cells was evident, suggesting selective purging of dividing cells. Supporting this hypothesis, proliferating NK cells did not express aldehyde dehydrogenase and were killed by Cy in vitro. After ablation of mature NK cells, starting from day 15 after HSCT and favored by the high levels of interleukin-15 present in patients' sera, immature NK cells (CD62L+NKG2A+KIR-) became highly prevalent, possibly directly stemming from infused hematopoietic stem cells. Importantly, also putatively alloreactive single KIR+ NK cells were eliminated by PT-Cy and were thus decreased in numbers and antileukemic potential at day 30 after HSCT. As a consequence, in an extended series of 99 haplo-HSCT with PT-Cy, we found no significant difference in progression-free survival between patients with or without predicted NK alloreactivity (42% vs 52% at 1 year, P = NS). Our data suggest that the majority of mature NK cells infused with unmanipulated grafts are lost upon PT-Cy administration, blunting NK cell alloreactivity in this transplantation setting. © 2018 by The American Society of Hematology.
Original languageEnglish
Pages (from-to)247-262
Number of pages16
JournalBlood
Volume131
Issue number2
DOIs
Publication statusPublished - 2018

Fingerprint Dive into the research topics of 'NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications'. Together they form a unique fingerprint.

  • Cite this

    Russo, A., Oliveira, G., Berglund, S., Greco, R., Gambacorta, V., Cieri, N., Toffalori, C., Zito, L., Lorentino, F., Piemontese, S., Morelli, M., Giglio, F., Assanelli, A., Lupo Stanghellini, MT., Bonini, C., Peccatori, J., Ciceri, F., Luznik, L., & Vago, L. (2018). NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications. Blood, 131(2), 247-262. https://doi.org/10.1182/blood-2017-05-780668